Syngene International reports Q4 FY24 consolidated PAT at Rs. 188.6 Cr
Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility
Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal
New chemical method could cut waste from drug production
Bristol Myers Squibb and Cellares inks US$ 380 million capacity reservation for the manufacture of CAR T Cell Therapies
Subscribe To Our Newsletter & Stay Updated